Product logins

Find logins to all Clarivate products below.


Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers | Latin America (Supplemental) | 2015 | Market Analysis

The Latin American market for surgical hemostats, internal tissue sealants, and adhesion barriers represents a high-growth market with relatively low penetration compared to countries like the US, leaving room for new competitors to bring products to market and gain share through 2023.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the surgical hemostat, internal tissue sealant, and adhesion barrier market in Latin America, including country-level data for 4 major countries and aggregate data for the rest of Latin America, across a 10-year period.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market will experience steady moderate growth through 2035, supported by the gradual expansion of MIS volumes and selective adoption of highervalue…
Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectables market will expand through 2035, driven by ongoing product innovation and differentiation strategies among key competitors, as well as the increasing…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…